Biocon Limited (NSE:BIOCON)
India · Delayed Price · Currency is INR 380.50
+3.35 (0.89%)
Nov 4, 2025, 3:30 PM IST
Biocon Market Cap
Biocon has a market cap or net worth of 507.75 billion as of November 4, 2025. Its market cap has increased by 22.39% in one year.
Market Cap
507.75B
Enterprise Value
706.40B
Revenue
157.71B
Ranking
n/a
PE Ratio
118.60
Stock Price
380.50
Market Cap Chart
Since April 7, 2004, Biocon's market cap has increased from 45.41B to 507.75B, an increase of 1,018.07%. That is a compound annual growth rate of 11.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2025 | 507.75B | 16.12% |
| Dec 31, 2024 | 437.25B | 46.69% |
| Dec 29, 2023 | 298.08B | -4.59% |
| Dec 30, 2022 | 312.41B | -27.97% |
| Dec 31, 2021 | 433.73B | -21.37% |
| Dec 31, 2020 | 551.59B | 58.78% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.06T |
| Divi's Laboratories | 1.79T |
| Cipla | 1.21T |
| Apollo Hospitals Enterprise | 1.10T |
| Mankind Pharma | 984.02B |
| Zydus Lifesciences | 980.52B |
| Fortis Healthcare | 772.36B |
| Aurobindo Pharma | 661.47B |